Mettler-Toledo International (NYSE:MTD) Rating Increased to Outperform at Evercore ISI

Mettler-Toledo International (NYSE:MTD) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued on Thursday, MarketBeat Ratings reports. The firm presently has a $1,450.00 price objective on the medical instruments supplier’s stock, up from their previous price objective of $1,375.00. Evercore ISI’s price objective would indicate a potential upside of 18.50% from the company’s current price.

Other equities research analysts have also issued research reports about the stock. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating on the stock. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and boosted their target price for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Wells Fargo & Company decreased their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Stifel Nicolaus reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Finally, Robert W. Baird reduced their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research note on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $1,351.25.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,223.68 on Thursday. The firm has a fifty day moving average price of $1,259.52 and a two-hundred day moving average price of $1,358.61. The company has a market cap of $25.82 billion, a PE ratio of 32.99, a price-to-earnings-growth ratio of 4.21 and a beta of 1.13. Mettler-Toledo International has a fifty-two week low of $1,115.64 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Analysts expect that Mettler-Toledo International will post 40.42 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Elisha W. Finney sold 76 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Gerry Keller sold 140 shares of the business’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the transaction, the insider now owns 6 shares in the company, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

A number of institutional investors and hedge funds have recently modified their holdings of MTD. DT Investment Partners LLC lifted its position in shares of Mettler-Toledo International by 13.3% in the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock valued at $102,000 after buying an additional 8 shares during the last quarter. UMB Bank n.a. lifted its holdings in Mettler-Toledo International by 8.0% during the 3rd quarter. UMB Bank n.a. now owns 122 shares of the medical instruments supplier’s stock valued at $183,000 after purchasing an additional 9 shares during the last quarter. Suncoast Equity Management boosted its position in Mettler-Toledo International by 2.0% during the third quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock worth $690,000 after purchasing an additional 9 shares during the period. Bleakley Financial Group LLC increased its holdings in shares of Mettler-Toledo International by 1.2% in the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock valued at $1,135,000 after purchasing an additional 9 shares during the last quarter. Finally, Huntington National Bank raised its position in shares of Mettler-Toledo International by 20.0% in the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after purchasing an additional 9 shares during the period. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.